Fingerprint
Dive into the research topics where Debbie Robbrecht is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Ipilimumab and nivolumab followed by chemoradiotherapy as bladder-sparing treatment in muscle-invasive bladder cancer: a phase 2 trial
Mellema, J. J. J., Stockem, C. F., Herberts, C., Cheung, S. K., Vis, D. J., van Rhijn, B. W. G., Mertens, L. S., Boellaard, T. N., van Montfoort, M. L., Balduzzi, S., de Feijter, J. M., van der Mijn, J. C. K., Sharma, S., El Naggar, A. C., Boormans, J. L., Franckena, M., Meijer, R. P., Noteboom, J. L., Schaake, E. E. & Robbrecht, D. G. J. & 2 others, , 27 Feb 2026, In: Nature Medicine.Research output: Contribution to journal › Article › Academic › peer-review
-
Experiences of metastatic prostate cancer patients with a mainstream genetic testing pathway
Vlaming, M., Bleiker, E. M. A., Schijven, G., Kiemeney, L. A. L. M., van Melick, H. H. E., Hunting, J. C. B., Noordzij, M. A., Beeker, A., Somford, D. M., van der Poel, H. G., Wijburg, C. J., Wijsman, B. P., Hoekstra, R. J., van Moorselaar, R. J. A., van Bezooijen, B. P. J., Meijer, R. P., Busstra, M. B., van den Berg, H. P., Robbrecht, D. G. J. & Doornweerd, B. H. J. & 2 others, , 15 Feb 2026, In: International Journal of Cancer. 158, 4, p. 984-993 10 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile5 Downloads (Pure) -
Cergutuzumab Amunaleukin in Combination with Atezolizumab in Patients with Carcinoembryonic Antigen–Positive Advanced/Metastatic Solid Tumors
Melero, I., Tabernero, J., Steeghs, N., Robbrecht, D. G. J., Peters, S., Rizvi, N. A., O’reilly, E. M., Calvo, E., Eefsen, R. L., Leighl, N., Cervantes, A., Hafez, N., Habigt, C., Andersson, E., Dejardin, D., Rossmann, E., Quetglas, I. M., Babitzki, G., Duarte, J. & Adessi, C. & 5 others, , 1 Feb 2026, In: Clinical Cancer Research. 32, 3, p. 528-539 12 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile -
Carbon footprint and staff demands of surgery and chemoradiation for muscle-invasive bladder cancer
Rutten, V. C., Hesseling, S. A. W., Franckena, M., Zuiverloon, T. C. M., Robbrecht, D. G. J., IJzerman, M. J., Lin, W., Mes, D., Hunfeld, N. & Boormans, J. L., 3 Sept 2025, (E-pub ahead of print) In: BJU International. 136, 6, p. 1048-1056 9 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile21 Downloads (Pure) -
Pasritamig, a First-in-Class, Bispecific T-Cell Engager Targeting Human Kallikrein 2, in Metastatic Castration-Resistant Prostate Cancer: A Phase I Study
Stein, M. N., Vinceneux, A., Robbrecht, D., Doger, B., Autio, K. A., Schweizer, M. T., Calvo, E., Medina, L., Van Dongen, M., Deville, J. L., Bernard-Tessier, A., Ghosh, D., Shotts, K., Shen, F., Jaiprasart, P., Chaudhary, R., Wu, S., Cartee, L., Schnepp, R. & Gaut, D. & 4 others, , 1 Aug 2025, In: Journal of Clinical Oncology. 43, 22, p. 2515-2526 12 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile16 Citations (Web of Science)43 Downloads (Pure)